Author： Subramanian S.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.58, Iss.2, 1999-08, pp. : 312-313
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. :
Access to resources
Recommend
Palivizumab poor performer for prevention of RSV
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 623, 2011-01 ,pp. :
Palivizumab pharmacy programme cost saving in the US
Inpharma, Vol. 1, Iss. 1410, 2003-01 ,pp. :
Palivizumab prophylaxis safe for second RSV season
Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. :
Palivizumab for RSV prevention in high-risk children
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 520, 2007-01 ,pp. :